Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction
Authors:
- Gregg W StoneGSGregg W Stone
- Judy BouraJBJudy Boura
- Luiz MattosLMLuiz Mattos
- Harish ChandraHCHarish Chandra
- David CoxDCDavid Cox
- Lorelei GrinesLGLorelei Grines
- William O’nEillWOWilliam O’nEill
- Cindy GrinesCGCindy Grines
- 1 May 2003
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (9) , 1041-1045
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarctionJACC, 2002
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Local intramural heparin delivery during primary angioplasty for myocardial infarction: Results of the local PAMI pilot studyCatheterization and Cardiovascular Interventions, 1999
- Clinical and Angiographic Follow-Up After Primary Stenting in Acute Myocardial InfarctionCirculation, 1999
- Safety and Cost-Effectiveness of Early Discharge After Primary Angioplasty in Low Risk Patients With Acute Myocardial Infarction 11Research funding for this study was provided by unrestricted grants from Advanced Cardiovascular Systems, Santa Clara, California; Mallinckrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey.JACC, 1998
- Prospective, Multicenter Study of the Safety and Feasibility of Primary Stenting in Acute Myocardial Infarction: In-Hospital and 30-Day Results of the PAMI Stent Pilot Trial fn1fn1Funding for this study was provided in part by an unrestricted grant from Johnson & Johnson Interventional Systems, Warren, New Jersey.JACC, 1998
- Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.JACC, 1997
- A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa Clara, California; Mallinkrodt Medical, Inc., Saint Louis, Missouri; Datascope Corporation, Montvale, New Jersey; St. Jude Medical, Chelmsford, Massachusetts; and Siemens Corporation, Iselin, New Jersey.JACC, 1997
- A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agentsJACC, 1993